Viruses kill pancreatic tumors in preclinical model
(Medical Xpress) -- An intra-tumor injection of a virus prevented further growth of some pancreatic tumors and eradicated others in mouse models of pancreatic ductal adenocarcinoma. However, some tumors continued growing ...
Medical research
Mar 20, 2012 |
5 / 5 (3) |
0
|
Major study stops bladder cancer from metastasizing to lungs
The diagnosis of localized bladder cancer carries an 80 percent five-year survival rate, but once the cancer spreads, the survival rate at even three years is only 20 percent. A major study published today in the Journal of ...
Cancer
Mar 12, 2012 |
5 / 5 (1) |
0
|
Vandetanib doesn't up survival in non-small-cell lung cancer
(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 ...
Cancer
Mar 02, 2012 |
not rated yet |
0
Protein modified by researchers may reduce heart attack damage
Scientists modified a protein in the heart which dramatically reduced cell damage after heart attacks, according to new research published the American Heart Association journal Arteriosclerosis, Thrombosis an ...
Cardiology
Mar 01, 2012 |
5 / 5 (1) |
0
Researchers develop oxygen-generating biomaterial
Scientists at the Diabetes Research Institute have developed a revolutionary technique to provide critical oxygen for maintaining the survival of insulin-producing cells. This is the first time that scientists have been able ...
Medical research
Mar 01, 2012 |
5 / 5 (6) |
0
|
Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer
Over the past few decades, doctors have noted a surprising trend in cancer of the tonsils and base of the tongue. Though oral cancer previously appeared predominantly in elderly patients with a history of tobacco and alcohol ...
Cancer
Mar 01, 2012 |
5 / 5 (2) |
0
Researchers find potential solution to melanoma's resistance to vemurafenib
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Cancer
Feb 28, 2012 |
not rated yet |
0
|
Secondhand smoke results in graft rejection
A new study published in the American Journal of Transplantation reveals that cigarette smoke exposure, in a cause-effect manner, results in graft rejection that would have been prevented by certain drug treatments.
Surgery
Feb 23, 2012 |
5 / 5 (1) |
0
Stem cell implants boost monkeys with Parkinson's
Monkeys suffering from Parkinson's disease show a marked improvement when human embryonic stem cells are implanted in their brains, in what a Japanese researcher said Wednesday was a world first.
Parkinson's & Movement disorders
Feb 22, 2012 |
5 / 5 (1) |
0
Researchers study mitochondrial function, potential new therapeutic target for Alzheimer's disease
Researchers at Rush University Medical Center are conducting an early phase clinical trial of a novel drug therapy for patients with dementia due to Alzheimer's disease. The drug is a new compound called MSDC-0160, which ...
Alzheimer's disease & dementia
Feb 15, 2012 |
5 / 5 (2) |
0
Stem cell treatments improve heart function after heart attack
Stem cell therapy moderately improves heart function after a heart attack, according to a systematic review published in The Cochrane Library. But the researchers behind the review say larger clinical trials are needed to ...
Medical research
Feb 14, 2012 |
5 / 5 (1) |
0
Researchers find important 'target' playing role in tobacco-related lung cancers
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce ...
Cancer
Feb 09, 2012 |
5 / 5 (1) |
0
New therapy combination prolongs survival in dogs with lymphoma
A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The st ...
Cancer
Feb 07, 2012 |
5 / 5 (2) |
0
Four-week vaccination regimen knocks out early breast cancer tumors, researchers find
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete ...
Cancer
Jan 30, 2012 |
5 / 5 (4) |
0
|
New method to manage stress responses for more successful tumor removal
The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body's immune responses, ...
Cancer
Jan 30, 2012 |
not rated yet |
0
